Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and management of bladder cancer. Their comprehensive discussion summarizes the state-of-the-art in diagnosis and treatment, based on the latest understanding of bladder cancer's epidemiology, carcinogenesis, and tumor markers. Topics of particular interest include the role of genetics and molecular biology in evaluating bladder cancer clinically, the evaluation of the results of systemic treatment in advanced disease, the current status of tumor markers in...
Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and manageme...
This issue of the Medical Clinics of North America is a comprehensive monograph on urology for the internist.? Topics covered include bladder pain syndrome; prostatitis and chronic pelvic pain syndrome; prostatism and lower urinary tract obstruction; neurologic/obstructive voiding dysfunction; neurologic/obstructive voiding dysfunction; irritative voiding symptoms; HIV/AIDS and STDs of the urinary tract; hematuria; renal mass; decreasing renal function; urologic stone disease; PSA in prostate cancer; erectile dysfunction; male factor assessment in infertility; testicular mass; urologic...
This issue of the Medical Clinics of North America is a comprehensive monograph on urology for the internist.? Topics covered include bladder pain syn...
Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and management of bladder cancer. Their comprehensive discussion summarizes the state-of-the-art in diagnosis and treatment, based on the latest understanding of bladder cancer's epidemiology, carcinogenesis, and tumor markers. Topics of particular interest include the role of genetics and molecular biology in evaluating bladder cancer clinically, the evaluation of the results of systemic treatment in advanced disease, the current status of tumor markers in...
Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and manageme...